Skip to main content
. 2014 Aug 1;175(2):240–247. doi: 10.1016/j.ijcard.2014.04.270

Appendix Table A3.

Treatment over time among NSTEMI patients age ≥ 80 years (N = 43,487 in the UK; N = 33,003 in the UK), by country, N (%).

Admission year 2007 2008 2009 2010 2007–10
Received in-hospital angiography MINAP (UK) 8.1 10.3 15.3 17.7 13.1
RIKS-HIA (Sweden) 23.3 26.2 29.4 34.2 28.1
ACTION (US) 43.6 46.2 36.2 49.4 46.7
Received in-hospital PCI MINAP (UK) 5.0 6.4 8.6 10.7 7.8
RIKS-HIA (Sweden) 15.4 16.9 18.5 22.0 18.1
ACTION (US) 23.1 24.9 25.5 27.3 25.4
Received dual antiplatelet at discharge MINAP (UK) 64.3 64.6 66.2 68.3 65.9
RIKS-HIA (Sweden) 41.7 48.8 53.6 55.4 49.6
ACTION (US) 51.1 51.9 54.3 55.5 53.5
Received single antiplatelet at discharge MINAP (UK) 27.7 26.8 26.0 24.4 26.1
RIKS-HIA (Sweden) 43.1 37.6 34.3 32.8 37.1
ACTION (US) 40.1 38.8 37.0 36.2 37.8
Received beta blocker at discharge MINAP (UK) 63.7 65.6 68.9 71.4 67.6
RIKS-HIA (Sweden) 81.3 81.4 81.0 81.6 81.3
ACTION (US) 87.5 86.7 85.6 84.6 85.9
Received ACEI or ARB at discharge MINAP (UK) 68.1 68.1 70.0 70.9 69.3
RIKS-HIA (Sweden) 55.5 59.1 58.7 60.1 58.2
ACTION (US) 62.2 59.5 57.4 57.0 58.8
Received statin at discharge MINAP (UK) 84.8 84.1 85.3 86.2 85.1
RIKS-HIA (Sweden) 53.4 57.4 59.2 59.95 57.4
ACTION (US) 71.3 73.7 75.5 76.6 74.6